These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16998876)

  • 1. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M; Kurosaki H; Sairenji T
    J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines.
    Fukuda M; Ikuta K; Yanagihara K; Tajima M; Kuratsune H; Kurata T; Sairenji T
    Virology; 2001 Sep; 288(1):109-18. PubMed ID: 11543663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
    J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
    Inman GJ; Allday MJ
    J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T
    Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum factors potentiate hypoxia-induced hepatotoxicity in vitro through increasing transforming growth factor-beta1 activation and release.
    Kao YH; Jawan B; Goto S; Pan MC; Lin YC; Sun CK; Hsu LW; Tai MH; Cheng YF; Nakano T; Wang CS; Huang CJ; Chen CL
    Cytokine; 2009 Jul; 47(1):11-22. PubMed ID: 19457680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
    Kumar A; Rogers T; Maizel A; Sharma S
    J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt.
    Ju EM; Choi KC; Hong SH; Lee CH; Kim BC; Kim SJ; Kim IH; Park SH
    Biochem Biophys Res Commun; 2005 Mar; 328(4):1170-81. PubMed ID: 15708000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI; Park SH; Kim JW; Sausville EA; Kim HT; Nakanishi O; Trepel JB; Kim SJ
    Cancer Res; 2001 Feb; 61(3):931-4. PubMed ID: 11221885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines.
    Chaouchi N; Arvanitakis L; Auffredou MT; Blanchard DA; Vazquez A; Sharma S
    Oncogene; 1995 Oct; 11(8):1615-22. PubMed ID: 7478586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A kunitz-type protease inhibitor bikunin disrupts ligand-induced oligomerization of receptors for transforming growth factor (TGF)-beta and subsequently suppresses TGF-beta signalings.
    Yagyu T; Kobayashi H; Wakahara K; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    FEBS Lett; 2004 Oct; 576(3):408-16. PubMed ID: 15498571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
    Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
    Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
    Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
    Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.